NCT02238171View on ClinicalTrials.gov

Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease

CompletedOBSERVATIONAL
Enrollment

346

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

December 31, 2000

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Atrovent® inhalets

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY